Penicillamine in the treatment of scleroderma. Lathyrogenic drugs
Szczepanski, A.
Przeglad Dermatologiczny 58(3): 355-359
1971
ISSN/ISBN: 0033-2526 PMID: 4944035 Document Number: 39951
Document emailed within 1 workday
Related Documents
Gauthier, Y.; Surlève-Bazeille, J.E.; Gauthier, O.; Texier, L. 1973: Ultrastructural comparative study of the behavior of collagen tissue and elastic tissue during 3 pathological states (Marfans disease, scleroderma due to vitamin K-1 lathyrogenic effect of penicillamine) Annales de Dermatologie et de Syphiligraphie 100(5-6): 525-529De la Espriella, J.; Crickx, B. 1991: Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs Annales de Dermatologie et de Venereologie 118(12): 948-953
Rosada, M.; Fiocco, U.; De Silvestro, G.; Doria, A.; Cozzi, L.; Favaretto, M.; Todesco, S. 1993: Effect of D-penicillamine on the T cell phenotype in scleroderma. Comparison between treated and untreated patients Clinical and Experimental Rheumatology 11(2): 143-148
Ziegler, V.; Haustein, U.F.; Mehlhorn, J.; Münzberger, H.; Rennau, H. 1986: Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma? Dermatologische Monatschrift 172(2): 86-90
Vogel, H.C.; Wichmann, J.; Roseburg, B.; Fikentscher, R. 1974: Isolated taste disorders as side-effects of drugs: observations on D-penicillamine and D,L-oxyfedrine Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(11): 452-454
Oroszlán, G.; Sanderud, J.; Saugstad, O.D.; Lakatos, L. 1992: D-penicillamine: old drug, new indication? D-penicillamine reduced pulmonary hypertension induced by free radicals Orvosi Hetilap 133(44): 2835-2836; 2839
Otomo, S.; Nakaike, S.; Tsuji, I.; Mori, C.; Ohzeki, M. 1981: Studies of D-penicillamine (3): immunomodulating effects of D-penicillamine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(3): 313-320
Veys, E.M.; Mielants, H.; Verbruggen, G. 1987: Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study Clinical and Experimental Rheumatology 5(2): 111-116
Folwaczny, C.; Läritz, M.; Meurer, M.; Endres, S.P.; König, A.; Schindlbeck, N. 1997: Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma Zeitschrift für Gastroenterologie 35(10): 905-912
Azuma, T.; Sugawara, S.; Maeda, A.; Miyauchi, T.; Aritomi, H. 1986: Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment Ryumachi 26(3): 200-209
Ishikawa, H.; Suzuki, S.; Horiuchi, R.; Sato, H. 1975: An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma Acta Dermato-Venereologica 55(2): 97-107
Giordano, M.; Valenti, G. 1986: Linear scleroderma plus systemic sclerosis sine scleroderma plus neuromyopathy of one upper limb: a new entity? Journal of Rheumatology 13(3): 656-657
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Kochetov, D.P.; Krivosheev, B.N. 1976: Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma Vestnik Dermatologii i Venerologii 1: 64-68
Madsen, K.L.; Hansen, A.; Halberg, P.; Ullman, S. 2014: Development of scleroderma renal crisis in a patient with undiagnosed scleroderma Ugeskrift for Laeger 176(25a)
Jablonska, S.; Blaszczyk, M. 1999: Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis European Journal of Dermatology: Ejd 9(7): 551-554
Recordier, A.M.; Roux, H.; Mercier, P.; Maestracci, D.; Schiano, A. 1976: Immunologic abnormalities during treatment with penicillamine Annales de Medecine Interne 127(8-9): 566-570
Black, C.M. 1994: Prognosis and management of scleroderma and scleroderma-like disorders in children Clinical and Experimental Rheumatology 12(Suppl 10): S75-S81
Haustein, U.F.; Ziegler, V. 1986: Scleroderma and scleroderma-like diseases caused by environmental pollutants Dermatosen in Beruf und Umwelt. Occupation and Environment 34(3): 61-67
Gros, H.; Zwirner, K. 1974: Treatment of chronic aggressive hepatitis with D-Penicillamine Medizinische Klinik 69(8): 333-337